Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.51M Sell
9,249
-1,197
-11% -$212K 0.01% 790
2026
Q1
$1.58M Buy
10,446
+1,101
+12% +$167K 0.01% 694
2025
Q4
$994K Sell
9,345
-1,102
-11% -$124K 0.01% 817
2025
Q3
$1.1M Buy
10,447
+330
+3% +$29.6K 0.01% 787
2025
Q2
$855K Buy
10,117
+2,836
+39% +$191K 0.01% 804
2025
Q1
$427K Buy
7,281
+870
+14% +$70K 0.01% 1119
2024
Q4
$518K Buy
6,411
+1,576
+33% +$124K 0.01% 925
2024
Q3
$386K Buy
4,835
+1,087
+29% +$106K 0.01% 1051
2024
Q2
$469K Buy
3,748
+862
+30% +$82.3K 0.01% 922
2024
Q1
$242K Buy
+2,886
New +$227K 0.01% 1129

Other funds holding CAMT

Vident Advisory's CAMT Position: Q2 2026 in Review

Vident Advisory reduced its Camtek (CAMT) stake by 11% in Q2 2026, selling an estimated $212K and leaving 9,249 shares worth $1.51M. The position accounts for 0.01% of the portfolio, ranked #790.

Vident Advisory first reported a position in CAMT in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.58M in Q1 2026. 235 funds tracked by Wall St. Rank hold CAMT as of Q2 2026.

  • Vident Advisory held 9,249 shares of Camtek worth $1.51M as of Q2 2026.
  • Vident Advisory sold 1,197 Camtek shares in Q2 2026, an estimated $212K.
  • Camtek made up 0.01% of Vident Advisory's portfolio in Q2 2026, its #790 holding.
  • Vident Advisory first reported a position in Camtek in Q1 2024 and has held it in 10 quarters since.
  • Vident Advisory's Camtek position peaked at $1.58M in Q1 2026.
  • 235 funds tracked by Wall St. Rank held Camtek as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.